News | Mammography | June 08, 2017

Are Mammograms Overdiagnosing Small Tumors?

According to Yale Cancer Center experts, many small breast cancers have promising prognosis

mammogram

Photo courtesy of Barco

An analysis of breast cancer data revealed that many small breast cancers have an excellent prognosis because they are inherently slow growing, according to Yale Cancer Center experts. Often, these cancers will not grow large enough to become significant within a patient's lifetime and subsequently early detection could lead to overdiagnosis, said the reseachers. In contrast, large tumors that cause most breast cancer deaths often grow so quickly that they become intrusive before they can be detected by screening mammography, they note.

The study, published June 8 in the New England Journal of Medicine, questions the value of breast cancer early detection.

"Our analysis explains both how mammography causes overdiagnosis and also why it is not more effective in improving outcomes for our patients. More importantly, it questions some of our fundamental beliefs about the value of early detection," said Donald R. Lannin, M.D., professor of surgery at Yale School of Medicine and lead author on the paper.

The research team analyzed invasive breast cancers diagnosed between 2001 and 2013 in the Surveillance, Epidemiology, and End Results (SEER) database and divided them into three prognostic groups based on biologic factors: grade, estrogen receptor (ER) status, and progesterone-receptor (PR) status. The three biologic categories were defined as favorable, intermediate, and unfavorable.

The team, which also included Shiyi Wang, M.D., assistant professor of epidemiology at Yale School of Public Health, then used the expected rate of overdiagnosis of 22% to model the types of breast cancers and patient age ranges that likely account for the majority of overdiagnosis. The results showed that most overdiagnosis occurred in older patients with biologically favorable, slow-growing tumors.

"Until now, we thought that the lead time, or time until a cancer becomes problematic for a patient, for most breast cancers was about three or four years. This paper shows that lead times vary widely depending on the tumor type. A large portion of aggressive cancers have a lead time of two years or less, whereas another large portion of breast cancers grow so slowly that the lead time is 15 to 20 years," Lannin explained.

"It is important that we educate physicians, patients, and the public on the indolent, slow-growing nature of some breast cancers. This knowledge will allow us to individualize treatment options, provide 'personalized medicine,' and avoid the major harms of overdiagnosis, which can result in overtreatment and the anxiety and fear that a cancer diagnosis causes," Lannin said.

For more information: www.nejm.org

Related Content

Sponsored Content | Webinar | Breast Imaging | April 23, 2018
Join Troy Voeltz, M.D., and Phyllis Fulk, administrator at Imaging for Women, Kansas City, Mo., sharing insights in g
ABUS: An Important Companion to Traditional Mammography

The multi-use ultrasound breast system Acuson S2000 Automated Breast Volume Scanner (ABVS) from Siemens Healthineers automatically acquires volume images of the breast. Photo courtesy of Siemens.

Feature | Ultrasound Women's Health | April 18, 2018 | Emily Clemons
Research shows that automated br...
DenseBreast-info.org Celebrates Third Anniversary
News | Breast Density | April 17, 2018
April 2018 marks the third anniversary of the launch of DenseBreast-info.org, the educational resource for medically...
Technology | Breast Density | April 13, 2018
Densitas Inc. has received U.S. Food and Drug Administration (FDA) clearance for its DENSITAS|density automated breast...
Volpara Solutions and Mammography Educators Launch Mammography Positioning Training Videos
News | Mammography | April 12, 2018
Volpara Solutions Inc. and mammography education provider Mammography Educators LLC announced the launch of training...
Ikonopedia Introduces Enhanced Breast Ultrasound Reporting Module at SBI
News | Ultrasound Women's Health | April 11, 2018
Ikonopedia will introduce its next-generation breast ultrasound reporting module at the 2018 Society for Breast Imaging...
ACR/SBI Breast Cancer Screening Guidelines Reclassify African-American Women as High-Risk
News | Breast Imaging | April 06, 2018
New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines are the...
News | Oncology Diagnostics | April 05, 2018
April 5, 2018 — Myriad Genetic Laboratories Inc.
Wisconsin Gov. Walker Signs Breast Density Reporting Bill
News | Breast Density | April 05, 2018 | Jeff Zagoudis, Associate Editor
Wisconsin Gov. Scott Walker made the Badger State the 35th state to report dense breast tissue to patients as part of...
Diagnosing Breast Cancer Using Red Light

Schematic diagram for OM instrument: Seven pulsed lasers sequentially illuminate the compressed breast; transmitted light is detected by the 8-channel SiPM probe and the TDC acquires the signal. Credit: Edoardo Ferocino

News | Breast Imaging | April 02, 2018
Optical mammography (OM), which uses harmless red or infrared light, has been developed for use in conjunction with X-...
Overlay Init